关注
Manmohan Singh
Manmohan Singh
Beam Tx
在 beamtx.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Nonviral delivery of self-amplifying RNA vaccines
AJ Geall, A Verma, GR Otten, CA Shaw, A Hekele, K Banerjee, Y Cu, ...
Proceedings of the National Academy of Sciences 109 (36), 14604-14609, 2012
7102012
Advances in vaccine adjuvants
M Singh, D O'Hagan
Nature biotechnology 17 (11), 1075-1081, 1999
7001999
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre …
APS Munro, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, M Bula, ...
The Lancet 398 (10318), 2258-2276, 2021
6812021
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
FA Sharp, D Ruane, B Claass, E Creagh, J Harris, P Malyala, M Singh, ...
Proceedings of the National Academy of Sciences 106 (3), 870-875, 2009
6552009
COVID-19 vaccine acceptance among health care workers in the United States
R Shekhar, AB Sheikh, S Upadhyay, M Singh, S Kottewar, H Mir, E Barrett, ...
Vaccines 9 (2), 119, 2021
6312021
Cationic microparticles: a potent delivery system for DNA vaccines
M Singh, M Briones, G Ott, D O'Hagan
Proceedings of the National Academy of Sciences 97 (2), 811-816, 2000
6222000
Recent developments in adjuvants for vaccines against infectious diseases
DT O'Hagan, ML MacKichan, M Singh
Biomolecular engineering 18 (3), 69-85, 2001
4702001
Recent advances in vaccine adjuvants
M Singh, DT O'Hagan
Pharmaceutical research 19, 715-728, 2002
3502002
A cationic nanoemulsion for the delivery of next-generation RNA vaccines
LA Brito, M Chan, CA Shaw, A Hekele, T Carsillo, M Schaefer, J Archer, ...
Molecular Therapy 22 (12), 2118-2129, 2014
3392014
Nanoparticles and microparticles as vaccine-delivery systems
M Singh, A Chakrapani, D O’Hagan
Expert review of vaccines 6 (5), 797-808, 2007
3252007
Poly (lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines
D T O'Hagan, M Singh, RK Gupta
Advanced Drug Delivery Reviews 32 (3), 225-246, 1998
3241998
Recent advances in veterinary vaccine adjuvants
M Singh, D T O'Hagan
International journal for parasitology 33 (5-6), 469-478, 2003
2932003
Microparticles as vaccine adjuvants and delivery systems
DT O’Hagan, M Singh
Expert review of vaccines 2 (2), 269-283, 2003
2722003
Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines
D O'Hagan, M Singh, M Ugozzoli, C Wild, S Barnett, M Chen, M Schaefer, ...
Journal of virology 75 (19), 9037-9043, 2001
2432001
Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice
A Wack, BC Baudner, AK Hilbert, I Manini, S Nuti, S Tavarini, H Scheffczik, ...
Vaccine 26 (4), 552-561, 2008
2392008
Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells
KS Denis-Mize, M Dupuis, ML MacKichan, M Singh, B Doe, D O'Hagan, ...
Gene therapy 7 (24), 2105-2112, 2000
2292000
Endotoxin limits in formulations for preclinical research
P Malyala, M Singh
Journal of pharmaceutical sciences 97 (6), 2041-2044, 2008
2212008
Commentary: acceptable levels of endotoxin in vaccine formulations during preclinical research
LA Brito, M Singh
Journal of pharmaceutical sciences 100 (1), 34-37, 2011
2142011
Microparticle-based technologies for vaccines
DT O’Hagan, M Singh, JB Ulmer
Methods 40 (1), 10-19, 2006
2092006
Rational design of small molecules as vaccine adjuvants
TYH Wu, M Singh, AT Miller, E De Gregorio, F Doro, U D’Oro, ...
Science translational medicine 6 (263), 263ra160-263ra160, 2014
1862014
系统目前无法执行此操作,请稍后再试。
文章 1–20